Plasma Fractionation Market is anticipated to grow at a CAGR of ~6.0% from 2019 to 2030
Market Industry Reports (MIR) has published a new report titled “Plasma Fractionation Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global plasma fractionation market is estimated to be over US$ 25 billion in 2019. It is anticipated to grow at a CAGR of ~6.0% from 2019 to 2030.
The continual growth of the plasma fractionation market can be attributed to several factors, which have led to the wide-scale adoption of these products. Moreover, growing demand for the plasma-derived products is anticipated to substantially contribute to the global market. To obtain better insights into the market scenario, prominent players are increasingly focusing on collaborative initiatives, new product launches, and partnerships. In 2018, GRIFOLs acquired certain number of plasma donation centers in the US with the help of Biotest Pharmaceutical Corporation.
The plasma fractionation market is driven by factors such as an increasing number of hemophilic patients, increasing prevalence of auto-immune disorders, increasing prevalence of respiratory disorders, and rising generic population, among others. The market is majorly driven by plasma-derived proteins having several therapeutic applications. Few of the application of plasma-derived proteins are- utilization as biomarkers in the diagnosis of diseases, treatment of acute liver failure maintenance of blood volume after a traumatic injury during surgery, and treatment of immunological disorders.
Moreover, an increase in the number of hemophilic patients is also one of the major factors contributing to market growth. Hemophilic patients require administration of coagulation factors on an everyday basis, this in turn increases the demand for plasma fractionation products at a global level.
Browse key industry insights spread across 160 pages with market data tables & figures & charts from the report, Plasma Fractionation Market by Product (Coagulation Factor Concentrates, Immunoglobulin, Protease Inhibitors and Albumin), Application (Immunology, Neurology, Critical Care, Hematology and Pulmonary), End users (Hospitals, Clinical Research Laboratories and Academic Institutions) - Analysis & Forecast 2019-2030 in detail along with the table of contents:https://www.marketindustryreports.com/plasma-fractionation-market/166
Hoverer, high cost of the plasma-derived protein, owing to costs associated with purification of proteins is one of the major factors hindering the growth of the market. Moreover, stringent government regulations, limited reimbursement, and the emergence of recombinant proteins as an alternative for plasma-derived proteins are anticipated to hinder the growth the of plasma fractionation market to a certain extent.
North America dominated the global plasma fractionation market followed by Europe in 2018, owing to rising prevalence of autoimmune disorders, respiratory & neurological disorders, growing generic population, and increasing number of hemophilic patients and growing range of therapeutic application of plasma-derived proteins. Asia-Pacific is expected to witness the highest CAGR during the forecast period owing to rising number of hemophilic patients among developing countries, increasing prevalence of autoimmune disorders, and increasing generic population in this region.
Some prominent players in the plasma fractionation market include Octapharma AG, CSL Ltd., China Biologics Products Holdings, Inc., Baxter International Inc., Kendrion, Biotest, Shanghai RAAS blood products Co., Ltd., GRIFOLs, Takeda Biopharmaceuticals, and Bio Products Laboratory, among others.
Market Industry Reports is a global leader in market measurement and advisory services. It is a 100% subsidiary of ExlTech. The firm has always been at the forefront of innovation to address worldwide industry trends and opportunities. We offer our clients a unique depth of market intelligence in an actionable format to move their business forward. Our analysis incorporates consumer study in more than 100 countries, providing a tactical approach to drive sustained business growth. We continue to pioneer state-of-the-art approach in research & analysis that will help you to overcome complexities and stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence, we unfold contingencies for our clients in the evolving world of technology, mega-trends, and industry convergence. We inspire our clients to empower and shape their businesses and to build world-class products.